Long-Term Investigative Follow-Up in TrialNet Study (TN16 LIFT)
Study Design: Observational only
Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1
Available Genotype Data: No
Image Summary: No
Transplant Type: None
Does it have dialysis patients: No
Access to samples for Long-Term Investigative Follow-Up in TrialNet Study (TN16 LIFT) is currently only available via collaboration. Please contact the parent study to ask about ancillary study opportunities.
The LIFT Study is available nationwide to TrialNet participants who either:
Developed diabetes while being monitored in the Pathway to Prevention Study or during participation in any prevention trial. The purpose is to study people early in the disease process
Participated in any new onset studies. The purpose is to learn more about diabetes and if there are any long-term effects—good or bad—from the treatments used in these studies
Participants will be asked to return to a TrialNet site annually or semi- annually, based on their ongoing ability to produce insulin. Visits will include metabolic testing (i.e., Oral Glucose Tolerance Test and/or Mixed Meal Tolerance Test), HbAc1, and possibly other blood or urine tests.
To study subjects early in the Type 1 Diabetes process, and to study if there are any long-term effects from the treatments used in previous new onset studies.
Subjects that were previously enrolled in a TrialNet study for people newly diagnosed with type 1 diabetes
Subjects that developed type 1 diabetes while participating in the Pathway to Prevention Study or a TrialNet prevention study.
This study is ongoing.